Published in Br J Pharmacol on January 01, 1986
Desensitization of histamine H1 receptor-mediated inositol phosphate accumulation in guinea pig cerebral cortex slices. Br J Pharmacol (1993) 0.86
1,4-Dithiothreitol-induced changes in histamine H1-agonist efficacy and affinity in the longitudinal smooth muscle of guinea-pig ileum. Br J Pharmacol (1987) 0.77
Proceedings of the British Pharmacological Society. 10th-18th September 1986. Abstracts. Br J Pharmacol (1986) 0.75
Some quantitative uses of drug antagonists. Br J Pharmacol Chemother (1959) 41.90
STIMULANT ACTIONS OF VOLATILE ANAESTHETICS ON SMOOTH MUSCLE. Br J Pharmacol Chemother (1964) 5.01
Potentiation of pharmacological effects of histamine by histaminase inhibitors. J Physiol (1954) 2.85
[The inhibition of histaminase]. Experientia (1952) 2.77
Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science (1983) 1.78
The effect of disulfide bond reduction on the properties of cholinergic receptors in chick muscle. Mol Pharmacol (1971) 1.48
Histamine-induced inositol phospholipid breakdown in the longitudinal smooth muscle of guinea-pig ileum. Br J Pharmacol (1985) 1.28
Role of disulfides in the subunit structure of the insulin receptor. Reduction of class I disulfides does not impair transmembrane signalling. J Biol Chem (1982) 1.20
Pharmacologic receptor activity of rabbit aorta. Effect of dithiothreitol and N-ethylmaleimide. Circ Res (1973) 1.16
Role of disulphide and sulphydryl groups in clustering of enkephalin receptors in neuroblastoma cells. Nature (1979) 1.09
New inhibitors of histamine-N-methyltransferase. Biochem Pharmacol (1979) 1.02
The acetylcholine receptor: progress report. Life Sci (1974) 0.99
Evidence for essential thiol groups and disulfide bonds in agonist and antagonist binding to the dopamine receptor. Biochem Biophys Res Commun (1980) 0.93
Modification of cardiovascular responses to histamine by dithiothreitol. Br J Pharmacol (1977) 0.88
Inactivation of angiotensin II receptors in bovine adrenal cortex by dithiothreitol: further evidence for the essential nature of disulfide bonds. Biochem Pharmacol (1982) 0.88
Uptake and metabolism of histamine in guinea pig ileal longitudinal muscle. Agents Actions (1978) 0.82
1,4-dithiothreitol non-specifically potentiates spasmogen actions on the guinea-pig ileum. Biochem Pharmacol (1982) 0.81
Chemical modification of the beta adrenergic receptors coupled with adenylate cyclase by disulfide bridge-reducing agents. Mol Pharmacol (1978) 0.81
Effect of dithiothreitol on histamine receptors in rabbit colon and guinea-pig ileum. Clin Exp Pharmacol Physiol (1979) 0.80
Effect of dithiothreitol on agonist and antagonist actions in frog muscle. J Pharm Pharmacol (1983) 0.79
Potentiation by sulphydryl agents of the responses of guinea-pig isolated ileum to various agonists. J Pharm Pharmacol (1984) 0.79
Transport and localization of exogenous myelin basic protein mRNA microinjected into oligodendrocytes. J Cell Biol (1993) 3.35
Graphical presentation of trends in rates. Am J Epidemiol (1995) 3.09
Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. Am J Transplant (2006) 2.48
G protein-coupled-receptor cross-talk: the fine-tuning of multiple receptor-signalling pathways. Trends Pharmacol Sci (1998) 1.83
Audio-visual presentation of information for informed consent for participation in clinical trials. Cochrane Database Syst Rev (2008) 1.73
Colonization of broiler chickens by waterborne Campylobacter jejuni. Appl Environ Microbiol (1993) 1.67
Specific binding of 3H-mepyramine to histamine H1 receptors in intestinal smooth muscle. Nature (1977) 1.61
Telling the truth: what do general practitioners say to patients with dementia or terminal cancer? Br J Gen Pract (1998) 1.57
Zinc, taurine, and epilepsy. Arch Neurol (1974) 1.52
An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis. Am J Transplant (2001) 1.48
Beta-adrenoceptor stimulation inhibits histamine-stimulated inositol phospholipid hydrolysis in bovine tracheal smooth muscle. Br J Pharmacol (1988) 1.48
Inhibition of histamine-stimulated inositol phospholipid hydrolysis by agents which increase cyclic AMP levels in bovine tracheal smooth muscle. Br J Pharmacol (1989) 1.38
Increases in intracellular calcium via activation of an endogenous P2-purinoceptor in cultured CHO-K1 cells. Br J Pharmacol (1993) 1.37
Agonist-occupied A3 adenosine receptors exist within heterogeneous complexes in membrane microdomains of individual living cells. FASEB J (2007) 1.32
Characterization of [3H]mepyramine binding to the longitudinal muscle of guinea pig small intestine. Mol Pharmacol (1981) 1.32
Microbial ecology of Campylobacter jejuni in a United Kingdom chicken supply chain: intermittent common source, vertical transmission, and amplification by flock propagation. Appl Environ Microbiol (1996) 1.29
Influence of rolipram on the cyclic 3',5'-adenosine monophosphate response to histamine and adenosine in slices of guinea-pig cerebral cortex. Biochem Pharmacol (1988) 1.29
The binding of [3H]mepyramine to histamine H1 receptors in guinea-pig brain. J Neurochem (1978) 1.28
Quantitative analysis of the formation and diffusion of A1-adenosine receptor-antagonist complexes in single living cells. Proc Natl Acad Sci U S A (2004) 1.28
Histamine-induced inositol phospholipid breakdown in the longitudinal smooth muscle of guinea-pig ileum. Br J Pharmacol (1985) 1.28
Influence of receptor number on functional responses elicited by agonists acting at the human adenosine A(1) receptor: evidence for signaling pathway-dependent changes in agonist potency and relative intrinsic activity. Mol Pharmacol (2000) 1.27
Reject analysis: its role in quality assurance. Radiography (1984) 1.23
Lymphadenitis as the dominant manifestation of Kawasaki disease. Pediatrics (1994) 1.23
Characteristics of the bradykinin-induced changes in intracellular calcium ion concentration of single bovine tracheal smooth muscle cells. Br J Pharmacol (1993) 1.19
Studies on the adenosine-receptor mediating the augmentation of histamine-induced inositol phospholipid hydrolysis in guinea-pig cerebral cortex. Br J Pharmacol (1987) 1.19
Adenosine inhibition of histamine-stimulated inositol phospholipid hydrolysis in mouse cerebral cortex. J Neurochem (1988) 1.19
Histamine H1-agonist potentiation of adenosine-stimulated cyclic AMP accumulation in slices of guinea-pig cerebral cortex: comparison of response and binding parameters. Br J Pharmacol (1982) 1.17
Differences in the adenosine receptors modulating inositol phosphates and cyclic AMP accumulation in mammalian cerebral cortex. Br J Pharmacol (1989) 1.15
Bradykinin B2 receptor-mediated phosphoinositide hydrolysis in bovine cultured tracheal smooth muscle cells. Br J Pharmacol (1992) 1.12
An endogenous A2B adenosine receptor coupled to cyclic AMP generation in human embryonic kidney (HEK 293) cells. Br J Pharmacol (1997) 1.09
Continuous source outbreak of campylobacteriosis traced to chicken. J Food Prot (2000) 1.07
Modulation of carbachol-induced inositol phosphate formation in bovine tracheal smooth muscle by cyclic AMP phosphodiesterase inhibitors. Biochem Pharmacol (1990) 1.07
Comparison of fixed-dose rosiglitazone/metformin combination therapy with sulphonylurea plus metformin in overweight individuals with Type 2 diabetes inadequately controlled on metformin alone. Exp Clin Endocrinol Diabetes (2007) 1.07
Involvement of G-protein betagamma subunits in coupling the adenosine A1 receptor to phospholipase C in transfected CHO cells. Eur J Pharmacol (1998) 1.07
A new ELISA kit for measuring urinary 2-hydroxyestrone, 16alpha-hydroxyestrone, and their ratio: reproducibility, validity, and assay performance after freeze-thaw cycling and preservation by boric acid. Cancer Epidemiol Biomarkers Prev (2000) 1.05
Adenosine A2B-receptor-mediated cyclic AMP accumulation in primary rat astrocytes. Br J Pharmacol (1994) 1.05
Increased cerebrospinal fluid 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in Kleine-Levin syndrome. Neurology (1984) 1.04
Characterization of histamine H3-receptors in guinea-pig ileum with H3-selective ligands. Br J Pharmacol (1990) 1.03
Affinities of histamine H1-antagonists in guinea pig brain: similarity of values determined from [3H]mepyramine binding and from inhibition of a functional response. J Neurochem (1981) 1.03
Histamine-induced hydrolysis of polyphosphoinositides in guinea-pig ileum and brain. Eur J Pharmacol (1986) 1.01
Adenosine A1-receptor stimulation of inositol phospholipid hydrolysis and calcium mobilisation in DDT1 MF-2 cells. Br J Pharmacol (1992) 1.00
Adenosine A1-receptor stimulated increases in intracellular calcium in the smooth muscle cell line, DDT1MF-2. Br J Pharmacol (1993) 0.99
A method for injecting substances into the circulation to reach rapidly and to maintain a steady level. With examples of its application in the study of carbohydrate and amino acid metabolism. Med Biol Eng (1975) 0.99
Two hundred living donor kidney transplantations under alemtuzumab induction and tacrolimus monotherapy: 3-year follow-up. Am J Transplant (2008) 0.98
Modulation of fluoroaluminate-induced inositol phosphate formation by increases in tissue cyclic AMP content in bovine tracheal smooth muscle. Br J Pharmacol (1990) 0.98
A comparison of A2 adenosine receptor-induced cyclic AMP generation in cerebral cortex and relaxation of pre-contracted aorta. Br J Pharmacol (1994) 0.97
Evidence for the presence of histamine H1-receptors in guinea-pig brain [proceedings]. Br J Pharmacol (1978) 0.97
Seizures in rats associated with divalent cation inhibition of NA + -K + -ATP'ase. Can J Biochem (1971) 0.97
Histamine H1-receptors in the brain of the guinea-pig and the rat: differences in ligand binding properties and regional distribution. Br J Pharmacol (1980) 0.97
Taurine in epilepsy. Lancet (1973) 0.97
The rapid achievement and maintenance of a steady level of an injected substance in the blood plasma. J Physiol (1974) 0.96
Characterization of the human brain putative A2B adenosine receptor expressed in Chinese hamster ovary (CHO.A2B4) cells. Br J Pharmacol (1996) 0.96
Sensitivity of histamine H3 receptor agonist-stimulated [35S]GTP gamma[S] binding to pertussis toxin. Eur J Pharmacol (1996) 0.96
Human adenosine A1 receptor and P2Y2-purinoceptor-mediated activation of the mitogen-activated protein kinase cascade in transfected CHO cells. Br J Pharmacol (1998) 0.96
Adenosine receptor-induced cyclic AMP generation and inhibition of 5-hydroxytryptamine release in human platelets. Br J Clin Pharmacol (1995) 0.96
Experimental Rift Valley fever in rhesus macaques. Arch Virol (1988) 0.95
Kinetic studies on the mechanism by which histamine H1 receptors potentiate cyclic AMP accumulation in guinea pig cerebral cortical slices. Mol Pharmacol (1988) 0.95
A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex. Br J Pharmacol (1994) 0.94
Agonist-induced changes in [Ca2+]i in N1E-115 cells: differential effects of bradykinin and carbachol. Eur J Pharmacol (1992) 0.94
Expression of muscarinic M3-receptors coupled to inositol phospholipid hydrolysis in human detrusor cultured smooth muscle cells. J Urol (1995) 0.94
Histamine H1-receptor-mediated calcium influx in DDT1MF-2 cells. Biochem J (1992) 0.93
Manganese neurotoxicity: a model for free radical mediated neurodegeneration? Can J Physiol Pharmacol (1982) 0.93
Large-amplitude undulatory fish swimming: fluid mechanics coupled to internal mechanics. J Exp Biol (1999) 0.93
Partial mediation by nitric oxide of the relaxation of human isolated detrusor strips in response to electrical field stimulation. Br J Clin Pharmacol (1993) 0.93
Homologous and heterologous desensitization of histamine H1- and ATP-receptors in the smooth muscle cell line, DDT1MF-2: the role of protein kinase C. Br J Pharmacol (1993) 0.92
Nonselective effects of the putative phospholipase C inhibitor, U73122, on adenosine A1 receptor-mediated signal transduction events in Chinese hamster ovary cells. Biochem Pharmacol (1998) 0.92
Non-competitive antagonism of beta(2)-agonist-mediated cyclic AMP accumulation by ICI 118551 in BC3H1 cells endogenously expressing constitutively active beta(2)-adrenoceptors. Br J Pharmacol (2000) 0.92
Histamine-stimulated increases in intracellular calcium in the smooth muscle cell line, DDT1MF-2. Biochem Pharmacol (1991) 0.92
Histamine H1-receptor-mediated inositol phospholipid hydrolysis in DDT1MF-2 cells: agonist and antagonist properties. Br J Pharmacol (1993) 0.92
Intracranial ring lesions: can we differentiate by computed tomography? Invest Radiol (1980) 0.91
Influence of receptor number on the stimulation by salmeterol of gene transcription in CHO-K1 cells transfected with the human beta2-adrenoceptor. Br J Pharmacol (1998) 0.91
Differential effect of sodium ions and guanine nucleotides on the binding of thioperamide and clobenpropit to histamine H3-receptors in rat cerebral cortical membranes. Br J Pharmacol (1995) 0.91
Synergy between the inositol phosphate responses to transfected human adenosine A1-receptors and constitutive P2-purinoceptors in CHO-K1 cells. Br J Pharmacol (1995) 0.90
1,4-Dithiothreitol-induced alteration in histamine H1-agonist binding in guinea-pig cerebellum and cerebral cortex. Eur J Pharmacol (1986) 0.90
Coupling of a transfected human brain A1 adenosine receptor in CHO-K1 cells to calcium mobilisation via a pertussis toxin-sensitive mechanism. Br J Pharmacol (1994) 0.90
Enhancement of histamine H1-receptor agonist activity by 1,4-dithiothreitol in guinea-pig cerebellum and cerebral cortex. J Neurochem (1986) 0.90
Treatment of persistent eustachian tube dysfunction in children with aerosolized nasal dexamethasone phosphate versus placebo. Ann Allergy (1982) 0.90
Quantitative analysis of neuropeptide Y receptor association with beta-arrestin2 measured by bimolecular fluorescence complementation. Br J Pharmacol (2010) 0.90
Effect of metformin plus roziglitazone compared with metformin alone on glycaemic control in well-controlled Type 2 diabetes. Diabet Med (2006) 0.89
Determination of Na + , K + , Mg 2+ , Cu 2+ , Zn 2+ , and Mn 2+ in rat brain regions. Can J Biochem (1973) 0.89
The use of balloon-expandable metallic stents in the treatment of pediatric tracheomalacia and bronchomalacia. Arch Otolaryngol Head Neck Surg (1999) 0.89
Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks. Cephalalgia (1998) 0.88
Expression of beta 2-adrenoceptors mediating cyclic AMP accumulation in astroglial and neuronal cell lines derived from the rat CNS. Biochem Pharmacol (1990) 0.88
Steroid-free tacrolimus monotherapy after pretransplantation thymoglobulin or Campath and laparoscopy in living donor renal transplantation. Transplant Proc (2005) 0.88
Histamine receptors branch out. Nature (1987) 0.88
Intracellular cross-talk between receptors coupled to phospholipase C via pertussis toxin-sensitive and insensitive G-proteins in DDT1MF-2 cells. Br J Pharmacol (1993) 0.87
Inhibition of forskolin-stimulated cyclic AMP formation by 1-aminocyclopentane-trans-1,3-dicarboxylate in guinea-pig cerebral cortical slices. J Neurochem (1992) 0.87
Inositol 1,4,5-trisphosphate generation and calcium mobilisation via activation of an atypical P2 receptor in the neuronal cell line, N1E-115. Br J Pharmacol (1992) 0.87
Agonist-induced desensitization of histamine H1 receptor-mediated inositol phospholipid hydrolysis in human umbilical vein endothelial cells. Br J Pharmacol (1994) 0.87
Clinical features of hematopoietic malignancies and related disorders among benzene-exposed workers in China. Benzene Study Group. Environ Health Perspect (1996) 0.87
Distribution and bioavailability of copper in farm effluent. Sci Total Environ (2003) 0.86